Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology

Long-Term Management and the Path Ahead

At a Glance

Long-term care for DDCH is individualized: regular neurology, hearing, liver, and developmental monitoring helps teams address seizures, dystonia, breathing or swallowing problems, communication needs, and changing support needs. Outlook varies by the genetic change and organ involvement.

Managing BCAP31-related syndrome is a marathon, not a sprint. Because the condition affects multiple systems—the brain, ears, and liver—long-term care focuses on consistent monitoring to catch and manage issues early. While the condition is often static or slowly changing, your child’s needs will evolve as they grow, requiring a flexible but structured surveillance plan [1][2].

Safety First: Urgent Care Guidelines

Children with DDCH can have medical vulnerabilities. Add a clearly labeled safety section directing families to their local emergency service for emergencies and to obtain an individualized seizure, swallowing, and respiratory plan from their clinicians. Seek immediate medical attention for:

  • Breathing or Aspiration: Choking or coughing with feeds, a wet/gurgly voice, blue color, or new respiratory distress [3].
  • Seizures: A prolonged seizure (over 5 minutes) or repeated seizures without recovery [4].
  • Liver Symptoms: Jaundice, dark urine, pale stools, unusual bleeding, severe dehydration, or marked sleepiness [5].
  • Neurological Changes: Rapidly worsening painful dystonia, sudden loss of skills, or new weakness [2].

An Illustrative Framework for Long-Term Monitoring

There is no single international “standard” schedule for DDCH, so your team will create an individualized plan. The following intervals are examples to individualize by age, symptoms, and equipment:

  • Neurology & Movement (Every 6–12 Months): Regular visits are needed to monitor for seizures, manage the progression of dystonia (muscle twisting), and adjust medications [2][3].
  • Audiology (At least Annually): Infants and children using hearing devices often require much more frequent assessment to ensure that communication needs are being met [4][2].
  • Liver Function (Varies by Result): Elevations in transaminases (AST/ALT) are reported in some individuals [5]. Your doctor will determine the frequency of blood tests based on these levels [6].
  • Developmental Assessments (Every 1–2 Years): Formal testing helps tailor educational plans and therapy goals (PT, OT, and Speech) [3].

Prognosis and Quality of Life

One of the hardest questions for parents is about the long-term outlook. In BCAP31-related syndrome, prognosis data is drawn from a limited number of cases, and the outlook depends heavily on deletion size, associated genes, organ involvement, and respiratory status rather than a simple label.

  • Intragenic DDCH: For children with mutations limited only to the BCAP31 gene, the literature describes a severe but often slowly changing neurological course [5]. While these children face significant lifelong challenges and may have shortened life expectancy due to complications like respiratory infections or severe seizures, some live through childhood and into young adulthood [7][5].
  • CADDS (Contiguous Gene Deletions): This larger deletion (affecting both BCAP31 and ABCD1) is associated with a much more severe path [8]. Reports indicate that these infants often face life-threatening complications, including severe liver failure (neonatal cholestasis) and lung disease, which can lead to early death in infancy or early childhood [8][5].
  • Milder Variants: A small number of males with “missense” variants have been reported to have slower progression [1][5].

Daily Management and Support

Beyond the medical appointments, daily life with DDCH involves managing the intersection of movement, communication, and basic needs.

  • Comfort First: Managing dystonia is not just about movement; it is about sleep and pain management. If a child’s muscles are constantly twisting, they may struggle to rest [9].
  • Communication is Connection: Finding a “voice” for your child—whether through signs, pictures, or high-tech devices—is one of the most powerful ways to reduce frustration and improve daily life [3].
  • Caregiver Support: A palliative or supportive care consultation is compatible with pursuing active therapies. It adds an extra layer of comfort and planning. Caregiver mental health is vital, and families are encouraged to seek rare-disease family-support organizations [3].

Common questions in this guide

How often should my child be monitored for DDCH?
There is no single schedule for every child. Illustrative plans may include neurology and movement visits every 6–12 months, hearing checks at least yearly, liver blood tests based on results, and formal developmental testing every 1–2 years; children with hearing devices or changing symptoms may need more frequent visits.
When should I seek emergency help for a child with DDCH?
Call your local emergency service for severe breathing trouble or choking and aspiration signs such as coughing with feeds, a wet or gurgly voice, or blue color. Seek urgent care for a seizure lasting more than five minutes or repeated seizures without recovery, jaundice, dark urine, pale stools, unusual bleeding, severe dehydration, marked sleepiness, sudden loss of skills, or new weakness. Ask clinicians for an individualized seizure, swallowing, and breathing plan.
What is the outlook for children with BCAP31-related DDCH?
Outlook varies with the exact genetic change, the size of any deletion, organ involvement, and breathing status. Children with changes limited to BCAP31 may have severe but slowly changing neurologic disease, while CADDS, a larger deletion involving BCAP31 and ABCD1, can cause serious liver and lung problems early in life. Some children with BCAP31-only changes live through childhood and into young adulthood, but individual outcomes cannot be predicted from the diagnosis alone.
What does CADDS mean for my child's care?
CADDS is a larger genetic deletion involving BCAP31 and ABCD1 and may require closer attention to liver, breathing, and other organ complications. Ask your care team whether ABCD1-related monitoring, including evaluation for adrenal insufficiency, is appropriate for your child.
How can we support dystonia, comfort, and communication at home?
Dystonia causes involuntary muscle twisting that can interfere with comfort and sleep, so ask the care team about pain, sleep, and medication support. Signs, pictures, hearing devices, or high-tech communication tools can give a child more ways to express needs, while physical, occupational, and speech therapy can support daily function and participation.
What are early signs of swallowing or aspiration problems?
Watch for coughing or choking during feeds, a wet or gurgly voice, blue color, or new breathing trouble. Contact the care team promptly and follow the individualized swallowing and respiratory plan; severe or rapidly worsening breathing problems require emergency care.

Get notified when new evidence is published on Developmental malformations-deafness-dystonia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    An X-Linked Ataxia Syndrome in a Family with Hearing Loss Associated with a Novel Variant in the BCAP31 Gene.

    Paucar M, Li T, Bergendal Å, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(4)):672-682 doi:10.1002/mds.30116.

    PMID: 39831730
  2. 2

    BCAP31-associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy.

    Albanyan S, Al Teneiji A, Monfared N, Mercimek-Mahmutoglu S

    American journal of medical genetics. Part A 2017; (173(6)):1640-1643 doi:10.1002/ajmg.a.38127.

    PMID: 28332767
  3. 3

    Whole exome sequencing reveals a dual diagnosis of BCAP31-related syndrome and glutaric aciduria III.

    Huggins E, Jackson DG, Young SP, Kishnani PS

    Molecular genetics and metabolism reports 2024; (40()):101117 doi:10.1016/j.ymgmr.2024.101117.

    PMID: 39101156
  4. 4

    Case Report: The first Korean familial case of BCAP31-related deafness, dystonia, and cerebral hypomyelination.

    Suh YA, Hwang J, Seo GH, et al.

    Frontiers in pediatrics 2024; (12()):1488095 doi:10.3389/fped.2024.1488095.

    PMID: 39911770
  5. 5

    Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants.

    Whalen S, Shaw M, Mignot C, et al.

    European journal of human genetics : EJHG 2021; (29(9)):1405-1417 doi:10.1038/s41431-021-00821-0.

    PMID: 33603160
  6. 6

    De novo mutation and skewed X-inactivation in girl with BCAP31-related syndrome.

    Kao HJ, Chiang HL, Chen HH, et al.

    Human mutation 2020; (41(10)):1775-1782 doi:10.1002/humu.24080.

    PMID: 32652807
  7. 7

    BCAP31-related syndrome: The first de novo report.

    Rinaldi B, Van Hoof E, Corveleyn A, et al.

    European journal of medical genetics 2020; (63(2)):103732 doi:10.1016/j.ejmg.2019.103732.

    PMID: 31330203
  8. 8

    Interstitial lung disease and pancreatic exocrine insufficiency in CADDS: Phenotypic expansion and literature review.

    Heath O, Pandithan D, Pitt J, et al.

    JIMD reports 2023; (64(5)):337-345 doi:10.1002/jmd2.12390.

    PMID: 37701323
  9. 9

    Long-Term Follow-Up with Video of a Patient with Deafness-Dystonia Syndrome Treated with DBS-GPi.

    Dulski J, Schinwelski M, Mandat T, et al.

    Stereotactic and functional neurosurgery 2016; (94(2)):123-5 doi:10.1159/000445078.

    PMID: 27100856

This page is for informational purposes only and does not constitute medical advice. Your child's neurology, audiology, and other clinicians should tailor monitoring, emergency plans, and treatment to your child's needs.